Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: J Immunol. 2019 Jun 15;202(12):3412–3422. doi: 10.4049/jimmunol.1800587

Figure 4. Oral maraviroc treatment inhibits glial inflammation in the SNpc of hemiparkinsonian monkeys.

Figure 4.

Monkeys displaying classical parkinsonian postures received maraviroc (1 mg/kg body wt/d) orally mixed with banana. After 30 d of treatment, nigral sections were double-labeled for Iba1 and iNOS (A) and GFAP and iNOS (B). Cells positive for Iba1 (C), GFAP (D) and iNOS (E) were counted using the olympus microsuite V software in two nigral sections (two images per slide) of each of four monkeys (n=4) per group. ap<0.001 vs. control; bp < 0.001 vs MPTP; ns, not significant vs MPTP.